文献速递瘢痕与激光烧伤

激光治疗增生性烧伤瘢痕:不良事件回顾性综述

Treatment of Hypertrophic Burn Scars With Laser Therapy: A Review of Adverse Events.
PubMed 文献 · Ann Plast Surg · 2023-09-19

该研究回顾性分析单机构2中心2019年5月1日至2021年6月1日接受点阵二氧化碳激光(FCL)治疗的170例烧伤瘢痕患者,共544次治疗,报告13次不良事件(2.4%),除5例(2.9%)外其余患者报告瘢痕症状改善,提示FCL治疗增生性烧伤瘢痕的不良事件较少。

要点

  • 170例患者共接受544次FCL治疗,平均每例3±2.23次(范围1至17次)。
  • 共报告13次不良事件(2.4%),包括疼痛加重5次(0.9%)、红斑加重3次(0.6%)、表皮脱落或水疱4次(0.7%)、感觉异常/麻木加重1次(0.2%)。
  • 除5例(2.9%)外,其余患者均报告瘢痕症状改善。

核心结论

  • 本研究表明FCL治疗增生性烧伤瘢痕相关不良事件较少。

研究设计与样本

  • 单机构2中心回顾性病历审查,纳入2019年5月1日至2021年6月1日接受FCL治疗的烧伤患者,共170例,其中男性77例(45.3%)、女性93例(54.7%),共接受544次FCL治疗。

主要发现

  • 170例患者共接受544次FCL治疗,平均每例治疗3±2.23次,范围1至17次。
  • 544次激光治疗中共报告13次不良事件(2.4%)。
  • 不良事件包括术后疼痛加重5次(0.9%)、激光部位感觉异常/麻木加重1次(0.2%)、红斑加重3次(0.6%)、表皮脱落或水疱4次(0.7%)。
  • 除5例(2.9%)外,其余患者均报告瘢痕症状改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hypertrophic scarring, characterized by excessive scar tissue formation, is a debilitating outcome that significantly impairs physical and psychosocial recovery after burn injury. Hypertrophic scarring affects a substantial proportion of burn survivors, with reported prevalence as high as 70%. Fractional CO 2 laser (FCL) therapy, a therapy commonly used in acne scar treatment or skin rejuvenation, has become popular in treating hypertrophic scars. Little is known regarding FCL's adverse events for burn scar treatment. We hypothesize that FCL is a safe treatment modality with minimal adverse events in the management of hypertrophic burn scars. This is a retrospective chart review of adverse events after FCL at 2 centers within a single institution. Burn patients undergoing FCL between May 1, 2019, and June 1, 2021 were included. Demographics, injury etiology, laser treatment details, and adverse events were collected. A total of 170 patients, 77 (45.3%) males and 93 (54.7%) females, underwent 544 FCL therapies for burn scars. The average number of treatments per patient was 3 ± 2.23, with a range of 1 to 17 sessions. From the total 544 laser therapy sessions, 13 adverse events (2.4%) were reported. There were 5 reports (0.9%) of increased postprocedural pain and 1 report (0.2%) of increased paresthesia/numbness to laser site. Three instances (0.6%) of increased erythema and 4 reports (0.7%) of epidermal sloughing or blistering were reported. All but 5 patients (2.9%) reported improvements to scar symptoms. This study demonstrates minimal adverse events associated with FCL for hypertrophic burn scar treatment.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Won P, Cooper M, Gillenwater TJ, et al. Treatment of Hypertrophic Burn Scars With Laser Therapy: A Review of Adverse Events. Ann Plast Surg. 2023. PMID: 37856225. doi:10.1097/SAP.0000000000003712

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。